MIA:
- WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
- WHO ATC Second Level (Therapeutic subgroup) ID: J05 ANTIVIRALS FOR SYSTEMIC USE
- WHO ATC Third Level (Pharmacological subgroup) ID: J05A DIRECT ACTING ANTIVIRALS
- WHO ATC Fourth Level (Chemical subgroup) ID: J05AE Protease inhibitors
- WHO ATC Fifth Level (Chemical substance) ID: J05AE10 Darunavir
- Chemical Name: Darunavir
- Chemical Smi: CC(CN(S(=O)(=O)c1ccc(cc1)N)C[C@H]([C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@@H]2[C@H]1CCO2)O)C
- WHO ICD Mapped Level : B20.4 B20.4 Name: HIV disease resulting in candidiasis
- WHO ICD Fourth Level ID: B20.4 B20.4 Name: HIV disease resulting in candidiasis
- WHO ICD Third Level ID: B20 B20 Name: Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
- WHO ICD Second Level ID: B20-B24 B20-B24 Name: Human immunodeficiency virus [HIV] disease
- WHO ICD First Level ID: I I Name: Certain infectious and parasitic diseases
|
|